Anti-Arthritic effects of magnolol in human interleukin 1β-Stimulated Fibroblast-Like synoviocytes and in a rat arthritis model

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Wang, Jyh Horng ^a   Shih, Kao Shang ^b   Liou, Jing Ping ^c   Wu, Yi Wen ^a   Chang, Anita Shin Yuan ^d   Wang, Kang Li ^d   Tsai, Ching Lin ^a   Yang, Chia Ron ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYCLOOXYGENASE 2; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MAGNOLOL; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR AP 1; AUTACOID; BIPHENYL DERIVATIVE; CYTOKINE; INTERLEUKIN 1BETA; LIGNAN; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BINDING AFFINITY; CELL STIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BLOOD; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; PATHOLOGY; SYNOVIUM; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; BIPHENYL COMPOUNDS; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROBLASTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIGNANS; MATRIX METALLOPROTEINASES; RATS; SYNOVIAL MEMBRANE; TREATMENT OUTCOME;

EID: 84863171722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031368     Document Type: Article

References (38)

1. Cooles FA, Isaacs JD, (2011) Pathophysiology of rheumatoid arthritis. Curr Opin Rheumatol 23: 233-240.
2. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H, (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7: 33-42.
3. Smolen JS, Steiner G, (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2: 473-488.
4. Scott DL, Wolfe F, Huizinga TWJ, (2010) Rheumatoid arthritis. Lancet 376: 1094-1107.
5. Boileau C, Martel-Pelletier J, Caron J, Msika P, Guillou GB, et al. (2009) Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13. Arthritis Res Ther 11: R41.
6. Gaby AR, (1999) Alternative treatments for rheumatoid arthritis. Altern Med Rev 4: 392-402.
7. Jacobs JWG, Kraaimaat FW, Bijlsma JW, (2001) Why do patients with rheumatoid arthritis use alternative treatments? Clin Rheumatol 20: 192-196.
8. Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, et al. (2011) Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther 130: 157-176.
9. Seventy-third meeting of the Joint FAO/WHO Expert Committee on Food Additive (JECFA) (2011) Safety evaluation of certain food additives and contaminants. WHO Food Additives Series.
10. Wang JP, Ho TF, Chang LC, Chen CC, (1995) Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J Pharm Pharmacol 47: 857-860.
11. Teng CM, Ko FN, Wang JP, Lin CN, Wu TS, et al. (1991) Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J Pharm Pharmacol 43: 667-669.
12. Hwang ES, Park KK, (2010) Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells. Biosci Biotechnol Biochem 74: 961-967.
13. Chen LC, Liu YC, Liang YC, Ho YS, Lee WS, (2009) Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J Agric Food Chem 57: 7331-7337.
14. Teng CM, Yu SM, Chen CC, Huang YL, Huang TF, (1990) EDRF-release and Ca+(+)-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci 47: 1153-1161.
15. Tsai YC, Cheng PY, Kung CW, Peng YJ, Ke TH, et al. (2010) Beneficial effects of magnolol in a rodent model of endotoxin shock. Eur J Pharmacol 641: 67-73.
16. Matsuda H, Kageura T, Oda M, Morikawa T, Sakamoto Y, et al. (2001) Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull 49: 716-720.
17. Schuhly W, Khan SI, Fischer NH, (2009) Neolignans from North American Magnolia species with cyclooxygenase 2 inhibitory activity. Inflammopharmacology 17: 106-110.
18. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL, (2002) Magnolol attenuates VCAM-1 expression in vitro in TNF-α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 135: 37-47.
19. Tse AK, Wan CK, Zhu GY, SHen XL, Cheung HY, et al. (2007) Magnolol suppresses NF-κB activation and NF-κB regulated gene expression through inhibition of IκB kinase activation. Mol Immunol 44: 2647-2658.
20. Park J, Lee J, Jung E, Park Y, Kim K, et al. (2004) In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 496: 189-195.
21. Barksby HE, Lea SR, Preshaw PM, Taylor JJ, (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149: 217-225.
22. Daheshia M, Yao JQ, (2008) The interleukin 1β pathway in the pathogenesis of osteoarthritis. J Rheumatol 35: 2306-2312.
23. Lin YR, Chen HH, Lin YC, Ko CH, Chan MH, (2009) Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain. J Biomed Sci 16: 94.
24. Kim KR, Park KK, Chun KS, Chung WY, (2010) Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of pro-inflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage. J Pharmacol Sci 114: 69-78.
25. Kao YH, Jawan B, Sun CK, Goto S, Lin YC, et al. (2010) High concentration of magnolol induces hepatotoxicity under serum-reduced conditions. Phytomedicine 17: 469-474.
26. Jawan B, Goto S, Pan TL, Lai CY, Luk HN, et al. (2003) The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver. J Surg Res 110: 378-382.
27. Suleyman H, Albayrak A, Bilici M, Cadirci E, Halici Z, (2010) Different mechanisms in information and prevention of indomethacin-induced gastric ulcers. Inflammation 33: 224-234.
28. Feldmann M, Andreakos E, Smith C, Bondeson J, Yoshimura S, et al. (2002) Is NF-κB a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 61 S2: ii13-18.
29. Aya K, Alhawagri M, Hagen-Stapleton A, Kitaura H, Kanagawa O, et al. (2005) NF-κB-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J Clin Invest 115: 1848-1854.
30. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, et al. (2010) Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev 15: 337-344.
31. Aikawa Y, Morimoto K, Yamamoto T, Chaki H, Hashiramoto A, et al. (2008) Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotech 26: 817-823.
32. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ, (1995) Integration of MAPK kinase signal transcription pathways at the serum response element. Science 269: 403-407.
33. Dayer JM, (2003) The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology 42 S2: ii3-10.
34. Kim HM, Bae SJ, Kim DW, Kim BK, Lee SB, et al. (2007) Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells. Int Immunopharmacol 7: 1083-1091.
35. Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR, (1983) Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219: 56-58.
36. Barsante MM, Roffe E, Yokoro CM, Tafuri WL, Souza DG, et al. (2005) Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur J Pharmacol 516: 282-289.
37. Shen YC, Sung YK, Chen CF, (1998) Magnolol inhibits Mac-1 (CD11b/CD18)-dependent neutrophil adhesion: relationship with its antioxidant effect. Eur J Pharmacol 343: 79-86.
38. Chen PH, Yang CR, (2008) Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-κB-dependent pathway. J Immunol 181: 8441-8449.